Target N. V. Biotech Purchases 50,000 Shares of Esperion Therapeutics Inc (ESPR) Stock

Target N. V. Biotech Purchases 50,000 Shares of Esperion Therapeutics Inc (ESPR) Stock


Esperion Therapeutics Inc major shareholder Target N. V. Biotech purchased 50,000 shares of Esperion Therapeutics stock in a transaction that occurred on Friday, June 29th. The shares were bought at an average cost of $39.48 per share, with a total value of $1,974,000.00.



from Biotech News